Additional statistical analysis was carried out comparing the SULF2 expression among TNBCs, ER+/PR+, HER2+ breast cancer, normal breast tissue, and DCIS (Supplemental Figure S7). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.